↓ Skip to main content

Schisandrin alleviates the cognitive impairment in rats with Alzheimer’s disease by altering the gut microbiota composition to modulate the levels of endogenous metabolites in the plasma, brain, and…

Overview of attention for article published in Frontiers in Pharmacology, September 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Schisandrin alleviates the cognitive impairment in rats with Alzheimer’s disease by altering the gut microbiota composition to modulate the levels of endogenous metabolites in the plasma, brain, and feces
Published in
Frontiers in Pharmacology, September 2022
DOI 10.3389/fphar.2022.888726
Pubmed ID
Authors

Chengqin Zhang, Ying Zhang, Tiantian Zhao, Tingting Mou, Wang Jing, Jian Chen, Wenqian Hao, Shuo Gu, Meirong Cui, Yue Sun, Binbin Wei

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 6 30%
Student > Bachelor 1 5%
Student > Master 1 5%
Unknown 12 60%
Readers by discipline Count As %
Unspecified 6 30%
Agricultural and Biological Sciences 2 10%
Unknown 12 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2022.
All research outputs
#13,594,398
of 23,443,716 outputs
Outputs from Frontiers in Pharmacology
#3,996
of 16,987 outputs
Outputs of similar age
#170,994
of 434,330 outputs
Outputs of similar age from Frontiers in Pharmacology
#201
of 1,502 outputs
Altmetric has tracked 23,443,716 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,987 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,330 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 1,502 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.